These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16435426)

  • 21. Lipoprotein(a) and coronary artery disease: ongoing debate.
    Celik T; Yuksel C; Iyisoy A; Isik E
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):e33-4. PubMed ID: 18472410
    [No Abstract]   [Full Text] [Related]  

  • 22. Natriuretic peptides for heart failure. Fashionable? Useful? Necessary?
    Cleland JC; Goode K
    Eur J Heart Fail; 2004 Mar; 6(3):253-5. PubMed ID: 14987572
    [No Abstract]   [Full Text] [Related]  

  • 23. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children.
    Maher KO; Reed H; Cuadrado A; Simsic J; Mahle WT; Deguzman M; Leong T; Bandyopadhyay S
    Pediatrics; 2008 Jun; 121(6):e1484-8. PubMed ID: 18519452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-type natriuretic peptides.
    Sisson D
    J Vet Cardiol; 2009 May; 11 Suppl 1():S5-7. PubMed ID: 19398397
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [NT-proBNP in practice: from chemistry to medicine].
    Jourdain P; Lefèvre G; Oddoze C; Sapin V; Dievart F; Jondeau G; Meune C; Galinier M
    Ann Cardiol Angeiol (Paris); 2009 Jun; 58(3):165-79. PubMed ID: 19457468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for heart failure in patients with one prior myocardial infarction episode.
    Mocan T; Agoşton-Coldea L; Gatfossé M; Rosenstingl S; Mocan LC
    Rom J Intern Med; 2008; 46(3):213-21. PubMed ID: 19366080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum lipids and neopterin in urine as new biomarkers of malnutrition and inflammation in the elderly.
    Hrnciarikova D; Hyspler R; Vyroubal P; Klemera P; Hronek M; Zadak Z
    Nutrition; 2009 Mar; 25(3):303-8. PubMed ID: 19019628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B type natriuretic peptide--a diagnostic breakthrough in peri-operative cardiac risk assessment?
    Rodseth RN
    Anaesthesia; 2009 Feb; 64(2):165-78. PubMed ID: 19143695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are multiple biomarker testing strategies ready for prime time in heart failure?
    Lee DS; Tu JV
    Circ Heart Fail; 2009 Sep; 2(5):387-8. PubMed ID: 19808366
    [No Abstract]   [Full Text] [Related]  

  • 31. Nitric oxide metabolites are associated with survival in older patients.
    Hayashi T; Nomura H; Osawa M; Funami J; Miyazaki A; Iguchi A
    J Am Geriatr Soc; 2007 Sep; 55(9):1398-403. PubMed ID: 17767681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-type natriuretic peptide is predictive of hospitalization in community-dwelling elderly without heart diseases.
    Shimizu Y; Nishinaga M; Takata J; Miyano I; Okumiya K; Matsubayashi K; Ozawa T; Yasuda N; Doi Y
    Geriatr Gerontol Int; 2009 Jun; 9(2):148-54. PubMed ID: 19740358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The associations between current recommendation for physical activity and cardiovascular risks associated with obesity.
    Akbartabartoori M; Lean ME; Hankey CR
    Eur J Clin Nutr; 2008 Jan; 62(1):1-9. PubMed ID: 17342166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan.
    Yokokawa H; Goto A; Terui K; Funami Y; Watanabe K; Yasumura S
    J Clin Neurosci; 2008 Jul; 15(7):769-73. PubMed ID: 18411050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-high-density lipoprotein cholesterol in secondary prevention of coronary artery disease: a unique risk factor or redundant information?
    Holcombe SM; Brubaker PH
    J Cardiopulm Rehabil Prev; 2007; 27(6):386-9. PubMed ID: 18197073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
    Glick A; Michowitz Y; Keren G; George J
    Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
    Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
    J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts.
    Rudiger A; Fischler M; Harpes P; Gasser S; Hornemann T; von Eckardstein A; Maggiorini M
    Int J Cardiol; 2008 May; 126(1):28-31. PubMed ID: 17477984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.